Cargando…
Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation
The field of organ transplantation has undoubtedly made great strides in recent years. Despite the advances in donor–recipient histocompatibility testing, improvement in transplantation procedures, and development of aggressive immunosuppressive regimens, graft-directed immune responses still pose a...
Autores principales: | Nayak, Deepak Kumar, Saravanan, Prathab Balaji, Bansal, Sandhya, Naziruddin, Bashoo, Mohanakumar, Thalachallour |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179571/ https://www.ncbi.nlm.nih.gov/pubmed/28066448 http://dx.doi.org/10.3389/fimmu.2016.00650 |
Ejemplares similares
-
Pancreatic β-Cell–Derived IP-10/CXCL10 Isletokine Mediates Early Loss of Graft Function in Islet Cell Transplantation
por: Yoshimatsu, Gumpei, et al.
Publicado: (2017) -
Withaferin A inhibits lymphocyte proliferation, dendritic cell maturation in vitro and prolongs islet allograft survival
por: Kumano, Kenjiro, et al.
Publicado: (2021) -
A comparison of the inflammatory response following autologous compared with allogenic islet cell transplantation
por: Chung, Wen Yuan, et al.
Publicado: (2021) -
Islet Cell Biology, Regeneration, and Transplantation
por: Balamurugan, A. N., et al.
Publicado: (2012) -
Immunoglobulin-Like Transcript 3-Fc Suppresses T-Cell Responses to Allogeneic Human Islet Transplants in hu-NOD/SCID Mice
por: Vlad, George, et al.
Publicado: (2008)